Weller M - Search Results

1

NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma.

Weiss T, Weller M, Guckenberger M, Sentman CL, Roth P. Weiss T, et al. Among authors: weller m. Cancer Res. 2018 Feb 15;78(4):1031-1043. doi: 10.1158/0008-5472.CAN-17-1788. Epub 2017 Dec 8. Cancer Res. 2018. PMID: 29222400 Free article.

2

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.

Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Wild-Bode C, et al. Among authors: weller m. Cancer Res. 2001 Mar 15;61(6):2744-50. Cancer Res. 2001. PMID: 11289157

3

Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.

Wischhusen J, Jung G, Radovanovic I, Beier C, Steinbach JP, Rimner A, Huang H, Schulz JB, Ohgaki H, Aguzzi A, Rammensee HG, Weller M. Wischhusen J, et al. Among authors: weller m. Cancer Res. 2002 May 1;62(9):2592-9. Cancer Res. 2002. PMID: 11980654

4

Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis.

Reichert M, Steinbach JP, Supra P, Weller M. Reichert M, et al. Among authors: weller m. Cancer. 2002 Sep 1;95(5):1113-9. doi: 10.1002/cncr.10767. Cancer. 2002. PMID: 12209698 Free article.

5

MICA/NKG2D-mediated immunogene therapy of experimental gliomas.

Friese MA, Platten M, Lutz SZ, Naumann U, Aulwurm S, Bischof F, Bühring HJ, Dichgans J, Rammensee HG, Steinle A, Weller M. Friese MA, et al. Among authors: weller m. Cancer Res. 2003 Dec 15;63(24):8996-9006. Cancer Res. 2003. PMID: 14695218

6

RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

Friese MA, Wischhusen J, Wick W, Weiler M, Eisele G, Steinle A, Weller M. Friese MA, et al. Among authors: weller m. Cancer Res. 2004 Oct 15;64(20):7596-603. doi: 10.1158/0008-5472.CAN-04-1627. Cancer Res. 2004. PMID: 15492287

7

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.

Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M. Uhl M, et al. Among authors: weller m. Cancer Res. 2004 Nov 1;64(21):7954-61. doi: 10.1158/0008-5472.CAN-04-1013. Cancer Res. 2004. PMID: 15520202

8

Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.

Roth P, Aulwurm S, Gekel I, Beier D, Sperry RG, Mittelbronn M, Meyermann R, Beaman KD, Weller M, Wischhusen J. Roth P, et al. Among authors: weller m. Cancer Res. 2006 Apr 1;66(7):3852-8. doi: 10.1158/0008-5472.CAN-05-3062. Cancer Res. 2006. PMID: 16585213

9

Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1.

Roth P, Mittelbronn M, Wick W, Meyermann R, Tatagiba M, Weller M. Roth P, et al. Among authors: weller m. Cancer Res. 2007 Apr 15;67(8):3540-4. doi: 10.1158/0008-5472.CAN-06-4783. Cancer Res. 2007. PMID: 17440061 Free article.

10

A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.

Weinmann L, Wischhusen J, Demma MJ, Naumann U, Roth P, Dasmahapatra B, Weller M. Weinmann L, et al. Among authors: weller m. Cell Death Differ. 2008 Apr;15(4):718-29. doi: 10.1038/sj.cdd.4402301. Epub 2008 Jan 18. Cell Death Differ. 2008. PMID: 18202704

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,713 results

Search Page

Filters